FINWIRES · TerminalLIVE
FINWIRES

NSE:NEPHROPLUS

4 stories mentioning NSE:NEPHROPLUSUpdated 40d ago

Every FINWIRES story that references NSE:NEPHROPLUS, newest first.

What are analysts saying about NSE:NEPHROPLUS?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on NSE:NEPHROPLUS?

Asia

Nomura Adjusts Nephrocare Health Services' Price Target to INR780 From INR680, Keeps at Buy

BSE:544647NSE:NEPHROPLUS
Asia

Nephrocare Unit To Acquire Dialysis Center Assets in Philippines

Nephrocare Health Services (NSE:NEPHROPLUS, BOM:544647) said its overseas step-down wholly owned subsidiary, Nephrocare Health Care Services Philippines, has entered into an asset transfer agreement to acquire assets related to a dialysis center in Parañaque City, Philippines, according to a filing.The assets are being acquired from Amica Healthcare System for a consideration of 32.6 million Philippine pesos, the filing said.The transaction covers identified assets of a dialysis center located in Dona Soledad, Don Bosco, Parañaque City, the company said.

BOM:544647NSE:NEPHROPLUS
Asia

Nephrocare Health Services Board Approves Up to INR1.4 Billion Support for Overseas Units

Nephrocare Health Services (NSE:NEPHROPLUS, BOM:544647) board approved collateral and security support of up to 1.40 billion Indian rupees for its overseas subsidiaries to help them obtain credit facilities from overseas banks, according to a filing.The board approved support of up to 700 million rupees for Nephrocare Health Services International, Singapore, and Nephrocare Health Services Saudi Arabia each, the filing said.Shares of the company fell nearly 6% in Wednesday's trade.

BOM:544647NSE:NEPHROPLUS
Research

IIFL Starts Nephrocare Health Services at Buy with INR700 Price Target

BOM:544647NSE:NEPHROPLUS

Track with the FINWIRES app suite